Virtu Financial’s Arcadia Biosciences RKDA Stock Holding History

Virtu Financial’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15K	Buy	+21,786	New	+$22.6K	﹤0.01%	1392
2024 Q1	–	Sell	-11,370	Closed	-$34K	–	1983
2023 Q4	$34K	Buy	+11,370	New	+$35.6K	﹤0.01%	1236
2023 Q1	–	Sell	-328	Closed	-$4K	–	2009
2022 Q4	$4K	Buy	+328	New	+$4.67K	﹤0.01%	1458
2022 Q1	–	Sell	-515	Closed	-$21K	–	1948
2021 Q4	$21K	Buy	+515	New	+$33.6K	﹤0.01%	1512
2020 Q3	–	Sell	-749	Closed	-$113K	–	1438
2020 Q2	$113K	Buy	+749	New	+$116K	0.01%	852
2019 Q4	$61K	Buy	+277	New	+$55.6K	0.01%	1174
2019 Q3	–	Sell	-497	Closed	-$61K	–	1773
2019 Q2	$61K	Buy	497 +153	+44%	+$32.5K	﹤0.01%	1211
2019 Q1	$96K	Sell	344 -298	-46%	-$62.3K	0.01%	1134
2018 Q4	$81K	Buy	642 +24	+4%	+$4.03K	﹤0.01%	1187
2018 Q3	$121K	Buy	+618	New	+$155K	0.01%	1164
2018 Q1	–	Sell	-128	Closed	-$28K	–	2491
2017 Q4	$28K	Buy	128 +109	+574%	+$23.6K	﹤0.01%	2172
2017 Q3	$6K	Buy	+19	New	+$6.96K	﹤0.01%	2429

Other funds holding RKDA

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BWM

Bullock Wealth Management Bloomington, Indiana $231M AUM

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Virtu Financial's RKDA Position: Q2 2026 in Review

Virtu Financial opened a new position in Arcadia Biosciences (RKDA) in Q2 2026: 21,786 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #1392 among its holdings. This is a return to the name: Virtu Financial previously reported a position in RKDA as recently as Q4 2023.

Virtu Financial first reported a position in RKDA in Q3 2017 and has held it in 12 quarters since. The position peaked at $121K in Q3 2018. 18 funds tracked by Wall St. Rank hold RKDA as of Q2 2026.

Virtu Financial held 21,786 shares of Arcadia Biosciences worth $15K as of Q2 2026.
Arcadia Biosciences was a new Virtu Financial position in Q2 2026.
Arcadia Biosciences made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1392 holding.
Virtu Financial first reported a position in Arcadia Biosciences in Q3 2017 and has held it in 12 quarters since.
Virtu Financial's Arcadia Biosciences position peaked at $121K in Q3 2018.
18 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.